The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Insightful Insights, IVO, Precision Toxicology and Efficacy News The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Ovarian cancer is the most lethal gynecological cancer in the [...] Jack Crawford2022-02-16T09:52:11+00:00Tags: Analise DiFeo, Cancer, Cancer Xenografts, Cell Line Xenografts, Chemo-induced stemness, drug discovery, drug resistance, gynecological Cancer, Hera Biolabs, Humanized Rats, Immunodeficient Rats, in vivo model, NSG Mice, Oncology, oncology models, OncoRat, OV81, OV81.2, ovarian cancer, preclinical, rat model, TCGA, The Cancer Genome Atlas, Xenografts| Read More